Home Cart Sign in  
Chemical Structure| 1418013-75-8 Chemical Structure| 1418013-75-8

Structure of NMS-873
CAS No.: 1418013-75-8

Chemical Structure| 1418013-75-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

NMS-873 is a selective p97/VCP inhibitor with high affinity for p97/VCP, with an IC50 value of 0.5 μM. NMS-873 is mainly used to study p97/VCP-related cellular processes such as protein degradation, cell cycle regulation, and cancer therapy.

Synonyms: VCP Inhibitor III

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of NMS-873

CAS No. :1418013-75-8
Formula : C27H28N4O3S2
M.W : 520.67
SMILES Code : O=S(C1=CC=C(C2=CC=C(OCC3=NN=C(SC4CCCC4)N3C5=CC=CN=C5)C=C2C)C=C1)(C)=O
Synonyms :
VCP Inhibitor III
MDL No. :MFCD28009371
InChI Key :UJGTUKMAJVCBIS-UHFFFAOYSA-N
Pubchem ID :71521142

Safety of NMS-873

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of NMS-873

DNA

Isoform Comparison

Biological Activity

Target
  • p97

    p97, IC50:30 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
HCT116 colorectal carcinoma cells 5 µM 6 hours Analyze the effects of NMS-873 on p97 enzyme composition, finding that NMS-873 treatment increases the binding of p97 to certain cofactors and ubiquitin. PMC4841942
HCT116 cells 2 µM 10 days Study the resistance mechanism of NMS-873, finding that the A530T mutation in the p97 gene can overcome the cytotoxicity of NMS-873. PMC4841942
HEK293T tau biosensor cells 100 nM 48 hours NMS-873 decreased tau seeding efficiency. PMC11707990
Human neurons 100 nM 48 hours NMS-873 suppressed tau seeding in human neurons. PMC11707990
human fibroblast cells 1μM 24 hours Treatment with NMS-873 resulted in loss of IE2 transcript and protein expression, indicating that NMS-873 inhibits HCMV replication by blocking VCP activity. PMC5426786
HCT116 colon cancer cells 4 μM 6 hours NMS-873 treatment promotes medium glucose consumption and lactate production PMC9024726
293T cells 4 μM 6 hours Overexpression of NDUFAF5-HA could significantly inhibit NMS-873-induced lactate production PMC9024726
KYSE70 120 nmol/L 24 hours NMS-873 reduced cell proliferation in a dose-dependent manner, with an IC10 value of 120 nmol/L. PMC6825005
KYSE140 90 nmol/L 24 hours NMS-873 reduced cell proliferation in a dose-dependent manner, with an IC10 value of 90 nmol/L. PMC6825005
KYSE70 cells 500 nM 24 hours NMS-873 significantly reduced the viability of KYSE70 cells from 100% ± 7.7% to 68% ± 3.3%. PMC10026871
KYSE140 cells 500 nM 24 hours NMS-873 significantly reduced the viability of KYSE140 cells from 100% ± 6.9% to 72% ± 2.9%. PMC10026871

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.92mL

0.38mL

0.19mL

9.60mL

1.92mL

0.96mL

19.21mL

3.84mL

1.92mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories